FDA Drug Recalls

Recalls / Brands / Rifampin

Rifampin

9 FDA drug recalls involving brand “Rifampin.

DateClassProductFirm
2024-01-11Class IIRifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American HAmerisource Health Services LLC
2024-01-05Class IIRifampin Capsules USP 300mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. BaltimorLupin Pharmaceuticals Inc.
2024-01-05Class IIRifampin Capsules USP 150mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. BaltimoLupin Pharmaceuticals Inc.
2022-12-20Class IIRifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health PacAmerisource Health Services LLC
2022-12-12Class IIRifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, MaLupin Pharmaceuticals Inc.
2022-07-28Class IIRifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc., Lupin Pharmaceuticals Inc.
2022-04-07Class IIRifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional Mylan Pharmaceuticals Inc
2019-10-07Class IIRifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61Mylan Laboratories Limited (Sterile Products Division)
2015-06-04Class IIRifampin for Injection, USP 600mg/vial in a 20mL vial, Rx only, Manufactured for Fresenius Kabi LLC 3 CorporatFresenius Kabi USA, LLC